Jazz Pharmaceuticals (JAZZ) Goodwill & Intangibles (2010 - 2026)

Jazz Pharmaceuticals' Goodwill & Intangibles history runs 17 years deep, the most recent figure standing at $6.0 billion for Q1 2026.

• In Q1 2026, Goodwill & Intangibles fell 7.25% year-over-year to $6.0 billion; the TTM figure through Mar 2026 stood at $6.0 billion (down 7.25% YoY), while the FY2025 annual figure was $6.3 billion, down 3.29% from the prior year.
• Goodwill & Intangibles was $6.0 billion for Q1 2026 at Jazz Pharmaceuticals, down from $6.3 billion in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $8.6 billion in Q1 2022 to a low of $2.5 billion in Q4 2023.
• Historically, Goodwill & Intangibles has averaged $6.7 billion across 5 years, with a median of $6.9 billion in 2024.
• The sharpest annual moves came in 2022 and 2023: Goodwill & Intangibles jumped 287.08% in 2022, then sank 66.53% in 2023.
• A 5-year view of Goodwill & Intangibles shows it stood at $7.5 billion in 2022, then tumbled by 66.53% to $2.5 billion in 2023, then surged by 158.3% to $6.5 billion in 2024, then retreated by 3.29% to $6.3 billion in 2025, then dropped by 3.99% to $6.0 billion in 2026.
• The last three Goodwill & Intangibles figures came in at $6.0 billion (Q1 2026), $6.3 billion (Q4 2025), and $6.4 billion (Q3 2025), per Business Quant data.